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2986Objectives: In patients with acute DeBakey type I dissection, endovascular repair of the descending thoracic
aorta during proximal aortic repair is an increasingly popular approach to preventing distal aortic sequelae and
subsequent repair. To better define the risks and outcomes associated with these secondary operations, we exam-
ined our contemporary experience with open distal aortic repair in patients with chronic type I aortic dissection.
Methods:Data were collected between January 2005 and June 2013 regarding 198 consecutive open descending
thoracic (n¼ 27) or thoracoabdominal (n¼ 171) aortic repairs performed in patients with chronic type I dissec-
tion. The median interval between the dissection onset and the subsequent distal operation was 5.0 years (inter-
quartile range, 2.4-10.5 years). A total of 110 repairs (56%) were performed in patients with genetic disorders.
Results: There were 14 early deaths (7%). Permanent paraplegia developed in 2 patients (1%), 5 patients (3%)
had permanent stroke, and 9 patients (5%) had permanent renal failure. Factors associated with early death
included greater age (P ¼ .01), chronic obstructive pulmonary disease (P ¼ .01), clamping proximal to the
left subclavian artery (P ¼ .004), and use of hypothermic circulatory arrest (P ¼ .002). The use of cold renal
perfusion (P<.001) was associated with early survival. Early death was not associated with genetic disorders,
emergency surgery, or extent of aortic repair. There were 36 late deaths, yielding an actuarial 8-year survival of
65.6%  5.9%. At 7 years, freedom from repair failure was 95.7%  1.7%, and freedom from subsequent
repair for disease progression was 84.8%  4.6%.
Conclusions: In survivors of DeBakey type I aortic dissection with distal aneurysm, open repair of the
descending thoracic or thoracoabdominal aorta can be performed with excellent early survival, acceptable
morbidity, and relatively few late aortic events. (J Thorac Cardiovasc Surg 2014;148:2986-94)Supplemental material is available online.
Acute DeBakey type I aortic dissection is life threatening
and necessitates emergency open proximal aortic repair.
However, the ideal approach to such repair remains
controversial. Although many centers, including our own,
generally prefer to limit the extent of repair in these casese Division of Cardiothoracic Surgery,a Michael E. DeBakey Department of
ry, Baylor College ofMedicine, Houston, Tex; Department of Cardiovascular
ry,b Texas Heart Institute, Houston, Tex; and Baylor St Luke’s Medical Cen-
ouston, Tex.
res: Joseph S. Coselli is a consultant for Vascutek Terumo and receives
ies for the Terumo branched graft for thoracoabdominal aortic repair.
ia Preventza reports consulting fees for Medtronic. Scott A. LeMaire reports
lting fees for Baxter and Medtronic. All other authors have nothing to
se with regard to commercial support.
the 94th Annual Meeting of The American Association for Thoracic
ry, Toronto, Ontario, Canada, April 26-30, 2014.
d for publication April 23, 2014; revisions received July 14, 2014; accepted
blication July 16, 2014; available ahead of print Sept 8, 2014.
for reprints: Joseph S. Coselli, MD, One Baylor Plaza, BCM 390, Houston,
7030 (E-mail: jcoselli@bcm.edu).
23/$36.00
ht  2014 by The American Association for Thoracic Surgery
.doi.org/10.1016/j.jtcvs.2014.07.048
The Journal of Thoracic and Cardiovascular Surin the hope of increasing early survival, an alternate strategy
is maximizing the initial repair in an attempt to prevent
distal aortic dilatation, reduce the need for subsequent distal
repair, and increase late survival.
A strategy recently has emerged that includes the antegrade
stent-graft placement in thedistal arch or proximal descending
thoracic aorta (DTA) as part of the evolving frozen elephant
trunk (FET) approaches. This increasingly popular approach
is thought to limit the distal aortic sequelae described; we
and others have selectively explored it.1-4 One of the
purported advantages of this strategy is the obliteration of
the corresponding section of the false lumen through (1) the
radial force exerted by the stent-graft or (2) simple thrombosis,
thereby reducing the rate of yearly aortic expansion and
the need for subsequent ‘‘high-risk’’ surgical repair of the
descending thoracic and thoracoabdominal aortic segments.
To better define the risks and outcomes associated with
these secondary operations, we examined our contemporary
experience in patients whose chronic dissection caused late
aneurysm formation and necessitated distal aortic repair.PATIENTS AND METHODS
Study Enrollment and Patient Characteristics
Following a protocol approved by the institutional review board at
Baylor College of Medicine, we identified 198 consecutive distal aorticgery c December 2014
Abbreviations and Acronyms
DTA ¼ descending thoracic aorta
FET ¼ frozen elephant trunk
HCA ¼ hypothermic circulatory arrest
IQR ¼ interquartile range
SSDI ¼ Social Security Death Index
TAAA ¼ thoracoabdominal aortic aneurysm
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Drepairs (Table 1) necessitated by late aneurysm formation in patients
with chronic DeBakey type I aortic dissection. Repairs were performed
between January 2005 and June 2013. Before May 2006, data were
collected retrospectively; afterward, data were collected prospectively
and entered in a departmental research database. Informed consent
was obtained from all patients enrolled after protocol approval, and a
waiver of consent permitted the inclusion of patients who were unable
to provide consent due to their illness and for those who underwent sur-
gery before protocol approval. In regard to study variables, operative
mortality (early death) was defined as death within 30 days of surgery
or before final hospital discharge, including any death that occurred af-
ter transfer to a secondary hospital or long-term acute care facility.
Adverse outcome is a composite endpoint that includes operative death
and permanent (at hospital discharge) stroke, renal failure necessitating
hemodialysis, paraplegia, or paraparesis.5 Genetic disorder was defined
as having a connective tissue disorder or the onset of aortic disease
before age 50 years.
The median age of onset of DeBakey type I aortic dissection was 48.8
years (interquartile range [IQR], 36.4-57.4 years), and the median time
to distal aortic repair necessitated by disease progression was 5.0 years
(IQR, 2.4-10.5 years). Most patients (n ¼ 165, 83%) had their proximal
repair performed elsewhere. Most repairs involved patients with a complex
aortic history; only 1 patient did not have a prior aortic repair. A total of 110
repairs (56%) were performed in patients with genetic disorders, including
70 (35%) with a connective tissue disorder.
Follow-up and Outcomes
Follow-up was obtained by clinic visit, telephone, or written corre-
spondence. Medical records were reviewed for late events, and late deaths
also were identified from the Social Security Death Index (SSDI); 6 pa-
tients were lost to follow-up but were indicated to be alive by the
SSDI. Clinical follow-up was available for 178 of 184 early survivors.
The median duration of follow-up for survivors was 3.7 years (range,
0.2-8.7 years; IQR, 2.2-5.6 years). Repair failure was defined as failure
directly related to the index distal aortic repair; failures related to prior
or subsequent aortic repair (open or endovascular) were not included
when determining specific outcomes of the index repair. Late repair for
disease progression was defined as subsequent aortic repair in an adjacent
aortic section.
Operative Technique
Our surgical approach to open repair of thoracoabdominal aortic an-
eurysms (TAAAs) related to chronic dissection (Table 2) has been
described.6 During extent I and II TAAA repairs and select extent III
repairs, left heart bypass is used as part of a multimodal approach to
preventing spinal cord ischemia; left heart bypass is established via
the left inferior pulmonary vein and the lower DTA. In acute dissection,
the false lumen is obliterated during the construction of the proximal
anastomosis. In chronic dissection, the thick septum is excised or fenes-
trated. When dissection extends into the origins of the visceral vessels,
the septum is excised or fenestrated, or the false lumen is sutured closed
or obliterated by placing a small balloon-expandable stent within theThe Journal of Thoracic and Cartrue lumen. Whenever the ostia of the renal arteries are accessible, a
cold solution is intermittently delivered to these vessels.7,8 The distal
anastomosis usually is constructed at the level of the aortic
bifurcation (or, occasionally, to each iliac or femoral artery
separately). In chronic dissection, the septum is fenestrated if the
dissection continues distally. The left renal artery is typically
reattached directly to an opening in the Dacron graft or via an 8- or
10-mm Dacron graft. Bowel viability, renal perfusion, and femoral
pulses are carefully evaluated at completion.
Data Presentation
Data were analyzed with Stata IC 13 (StataCorp LP, College Station,
Tex). Categoric variables are described as number and percentage.
Continuous variables are described as median with IQR. Univariate
comparisons were made with the Pearson chi-square test, Fisher exact
test, or Kruskal–Wallis equality-of-populations rank test, as appropriate.
Survival over time and freedom from late events were estimated by the
Kaplan–Meier method.RESULTS
Early Outcomes
Operative mortality occurred after 14 repairs (7.0%),
and adverse events occurred after 24 repairs (12.1%)
(Table 3). Permanent stroke occurred after 5 repairs
(2.5%), permanent paraplegia occurred after 2 repairs
(1.0%), and permanent renal failure necessitating dialysis
occurred after 9 repairs (4.6%). Early outcomes were
stratified by extent II TAAA repair versus all other
repairs and by genetic disorder versus no genetic disorder
(Table E1), but no significant differences were found. Of
note, patients in both of these selected subgroups were
substantially younger when they underwent distal aortic
repair; the median ages were 51.8 versus 58.7 years and
47.1 versus 62.0 years, respectively. Early deaths most
commonly resulted from stroke or pulmonary complication
(Table 4).
Univariate analysis was performed to identify associa-
tions with operative mortality and adverse event (Table 5).
Older age at the time of distal aortic repair was a risk factor
for both events (P¼ .01 and P¼ .005, respectively), as were
chronic obstructive pulmonary disease (P ¼ .01 and
P ¼ .007), aortic clamping proximal to the left subclavian
artery (P ¼ .004 and P ¼ .005), the use of hypothermic
circulatory arrest (HCA) (P ¼ .002 and P ¼ .006), and
major postoperative complications. Cold renal perfusion
appeared to be protective against operative death
(P<.001) and adverse events (P ¼ .03).Late Outcomes
Late deaths occurred in 36 of 184 early survivors
(19.6%). Twelve of these deaths were identified as aortic
related; 4 were related to repair failure, 2 were related to
subsequent repair for disease progression, and 6 were
related to additional aortic dissection (n ¼ 2), aortic
rupture (n ¼ 2), and nonadjacent aortic reoperation
(n ¼ 2). Another 9 late deaths had unknown causes.diovascular Surgery c Volume 148, Number 6 2987
TABLE 1. Preoperative characteristics of 198 distal aortic repairs in
patients with chronic DeBakey type I aortic dissection
Variable
Median (IQR);
range or no. (%)
Age at onset of DeBakey I dissection, y 48.8 (36.4-57.4);
12.4-75.4
Age at distal aortic repair, y 56.6 (45.7-62.3);
17.4-88.3
Time from DeBakey type I dissection to distal
aortic repair, y
5.0 (2.4-10.5);
0.1-28.7
Male 147 (74.2)
Genetic disorder 110 (55.6)
Connective tissue disease 70 (35.3)
Marfan syndrome 59 (29.8)
Loeys–Dietz syndrome 5 (2.5)
Other 6 (3.0)
Aortic disease onset at<50 y and without
CTD
40 (20.2)
Additional aortic dissection 17 (8.6)
Acute status 10 (5.0)
DeBakey I 1 (0.5)
DeBakey II 1 (0.5)
DeBakey III 15 (7.6)
Maximum distal aortic diameter, cm (n ¼ 189) 6.1 (5.5-6.9); 3.9-10.8
Maximal distal aortic diameter 8.5 cm
(n ¼ 189)
11 (5.8)
Diabetes 7 (3.6)
Hypertension 175 (88.4)
Coronary artery disease 65 (32.8)
Cerebrovascular disease 33 (16.7)
Chronic renal insufficiency 7 (3.5)
Chronic renal failure (dialysis) 6 (3.0)
Pulmonary disease (n ¼ 193) 71 (35.9)
Chronic obstructive pulmonary disease 41 (20.7)
Past or current tobacco use (n ¼ 192) 102 (51.5)
Extent of prior proximal aortic replacement* 197 (99.5)
Noney 1 (0.5)
Ascending aorta/aortic root 100 (50.5)
Ascending aorta/aortic root þ hemiarch 36 (18.2)
Ascending aorta/aortic root þ full arch 15 (7.6)
Ascending aorta/aortic root þ full arch with
elephant trunk
46 (23.2)
Extent of prior distal aortic replacement* 23 (11.6)
None 171 (86.4)
Descending thoracic 12 (6.1)
Extent I TAAA 5 (2.5)
Extent II TAAA 3 (1.5)
Extent III TAAA 0
Extent IV TAAA 0
Abdominal 3 (1.5)
Previous endovascular aortic repairz 12 (6.1)
Acute symptoms at time of repair 29 (14.7)
Rupture 7 (3.5)
Nonrupture-complicating factor at time of distal
aortic repair
7 (3.5)
Infected graft or endograft 2 (1.0)
Fistula 2 (1.0)
(Continued)
TABLE 1. Continued
Variable
Median (IQR);
range or no. (%)
Pseudoaneurysm 1 (0.5)
Intercostal or visceral patch aneurysm 3 (1.5)
CTD, Connective tissue disorder; IQR, interquartile range; TAAA, thoracoabdominal
aortic aneurysm. *For patients with multiple previous aortic repairs, the most compre-
hensive extent of prior graft replacement by aortic location is shown. yThis patient
presented with unrepaired chronic DeBakey type I aortic dissection. The proximal
aorta was not sufficiently dilated to warrant repair at the time of distal aortic repair.
zIncludes 4 prior hybrid aortic arch strategies (ie, modified FET, hemiarch with
antegrade TEVAR, and 2-stage hybrid elephant trunk approaches).
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DActuarial survival was 79.8%  2.9% at 2 years and
65.6%  5.9% at 8 years (Figure 1). There was no signif-
icant difference in survival when stratified by extent II
versus all other repairs or by genetic disorder versus no ge-
netic disorder (Figure E1). There were 7 site-specific late
repair failures (Table E2), which included the develop-
ment of a pseudoaneurysm in 3 repairs (with an intercostal
patch aneurysm in 1 of 3 repairs), fistula in 2 repairs, graft
infection in 1 repair, and recurrent graft infection withTABLE 2. Operative details (N ¼ 198)
Variable No. (%)
Urgency of operation
Elective 156 (78.8)
Urgent 28 (14.1)
Emergency 14 (7.1)
Aortic repair details
Extent of repair
DTA 27 (13.6)
Extent I 66 (33.3)
Extent II 80 (40.4)
Extent III 14 (7.1)
Extent IV 11 (5.6)
Redo thoracotomy 22 (11.1)
Extraction of endovascular graft 11 (5.6)
Reverse elephant trunk 21 (10.6)
Clamping proximal to left subclavian artery 78 (39.4)
Intercostal/lumbar artery reattachment 145 (73.2)
Bypass graft reattachment of intercostal/lumbar
artery
19 (9.6)
Visceral/renal bypass graft 59 (29.8)
With 4-branch graft 12 (6.1)
Visceral/renal endarterectomy 3 (1.5)
Visceral/renal stent 2 (1.0)
Iliac/femoral bypass graft 18 (9.1)
Adjuncts
Cerebrospinal fluid drainage 182 (91.9)
Left heart bypass* 140 (70.7)
HCA 16 (8.1)
Cold renal perfusion 122 (61.6)
Selective celiac/superior mesenteric artery perfusion 52 (26.3)
DTA, Descending thoracic aorta; HCA, hypothermic circulatory arrest. *Data avail-
able for 139 repairs; left heart bypass time averaged 28.2 minutes; median time
was 28.0 minutes (IQR, 23-33).
gery c December 2014
TABLE 3. Early outcomes (N ¼ 198)
Variable
Median (IQR) or
no. (%)
Adverse event* 24 (12.1)
Operative (early) death 14 (7.1)
In-hospital death 14 (7.1)
30-d death 9 (4.6)
Stroke 10 (5.1)
Permanent 5 (2.5)
Temporary 5 (2.5)
Permanent spinal cord deficits 6 (3.0)
Paraplegia 2 (1.0)
Paraparesis 4 (2.0)
Immediate 4 (2.0)
Delayed 2 (1.0)
Temporary spinal cord deficits 19 (9.6)
Acute renal dysfunction 26 (13.1)
Renal failure necessitating dialysis 14 (7.1)
Permanent 9 (4.6)
Temporary 5 (2.5)
Cardiac complication 56 (28.3)
Pulmonary complication 78 (39.4)
Necessitating tracheostomy 22 (11.1)
Left vocal cord paralysis 76 (38.4)
Bleeding requiring reoperation 15 (7.6)
Early survivors: length of intensive care unit stay, d 4 (3-9)
Early survivors: length of hospital stay, d 12 (9-20)
IQR, Interquartile range. *Adverse event is a composite endpoint that includes
operative death (in-hospital or 30-day death) and permanent (ie, present at hospital
discharge) stroke, renal failure, paraplegia, or paraparesis.
TABLE 4. Causes of operative mortality
Age (y) POD Cause of death
73 35 Pulmonary failure followed by MOF
73 11 Subdural hematoma necessitating craniotomy,
liver failure
89 100 Pulmonary failure followed by MOF
62 34 Pulmonary failure followed by sepsis and MOF
45 0 Heart failure
63 8 Exsanguination due to aortoesophageal fistula at
graft-to-graft anastomosis
67 6 Stroke, mesenteric ischemia
48 89 Metastatic lung cancer (discovered during repair)
50 5 Coagulopathy, bleeding, MOF
62 8 Stroke followed by MOF
67 4 Sudden cardiopulmonary arrest
70 50 Pulmonary failure
71 10 Stroke follwed by MOF
44 5 Coagulopathy and MOF
MOF, Multi-system organ failure; POD, postoperative day.
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Drecurrent fistula in 1 repair. Subsequent adjacent aortic
repair was necessary to treat disease progression after 17
repairs (Table E3), including 7 open aortic arch repairs
(all with prior repair limited to the ascending aorta), 5
further open distal aortic repairs, and 5 endovascular re-
pairs. At 7 years, freedom from repair failure was 95.7%
 1.7%, freedom from subsequent repair for disease pro-
gression was 84.8%  4.6%, and freedom from both
events was 81.1%  4.6% (Figure 1, B-D).DISCUSSION
Survivors of acute DeBakey I type aortic dissection
remain at risk for progressive dilation of the remaining
dissected aorta. Current guidelines9 indicate distal aortic
repair for these patients when a diameter-based threshold
for repair is reached (>5.5 cm), aortic growth is rapid
(>0.5 cm/y), or related symptoms develop. The develop-
ment of aortic dilatation necessitating distal aortic repair
in such patients is highly variable: Progressive dilatation
remains indolent in some patients, sparing them
additional distal aortic repair, but many DeBakey I
survivors eventually require 1 or more distal aortic repairs.
Repair for progression of aortic disease has been best
described in DeBakey I survivors with Marfan syndrome,
and the need for distal aortic repair is estimated to rangeThe Journal of Thoracic and Carfrom 25% to 50% at 5 years.10,11 In the current study of
198 such repairs (including 59 repairs in patients with
Marfan syndrome), the time from onset of DeBakey type
I aortic dissection to the index repair ranged from 44 days
to 29 years.
Should survivors of DeBakey I dissection need distal
aortic repair, what can they expect? In general, age remains
one of the best predictors of early death or adverse event.5
Because these patients are approximately a decade younger
than is typical for distal aortic repair,12 they often do better
than expected. In the current study, early death occurred
after 14 repairs (7%), and adverse events occurred after
24 repairs (12%). The rate of permanent paraplegia was
particularly low: 1%. This could be due to the ‘‘staged’’
nature of distal repair as necessitated by the progressive
nature of DeBakey I aortic dissection. Despite extensive
aortic dissection, only the aneurysmal section of the aorta
is replaced during repair; thus, in many of these patients,
a DTA repair may be followed by a TAAA repair or vice
versa. In our study, 23 repairs (12%) were performed in pa-
tients who had undergone prior distal aortic surgery, and 12
repairs (6%) were performed in patients who had under-
gone prior distal endovascular repair; also, 4 of our 17
late reinterventions involved extent III or IV TAAA repair
after previous DTA or extent I TAAA repair. Etz and col-
leagues13 suggest that staged extensive distal aortic repair
may facilitate the development of collateral circulation of
the spinal cord. Combining this approach with our aggres-
sive strategy of reperfusing select intercostal and lumbar
arteries through direct reattachment (n ¼ 126) or via a
small-diameter graft (n ¼ 19) may offer the best of both
worlds.
However, the overall risk of stroke in this series (n ¼ 10
[5%]; only 5 had permanent deficits) was greater than indiovascular Surgery c Volume 148, Number 6 2989
TABLE 5. Potential risk factors for operative (early) death or
composite adverse outcome
Variable
Operative
death (n ¼ 14)
P value
Adverse
event* (n ¼ 24)
P value
Preoperative
Increasing age at DeBakey I
dissection onset
.04 .07
Increasing age at distal aortic
repair
.01 .005
Male sex .8 .9
Chronic obstructive pulmonary
disease
.01 .007
Acute symptoms 1.0 .5
Rupture at presentation for repair .4 .2
Nonrupture-complicating factory 1.0 1.0
Genetic disorder .3 .6
Marfan syndrome .2 .1
Maximal distal aortic diameter
8.5 cm
.2 .1
Cerebrovascular disease 1.0 .8
Chronic renal dialysis .4 .5
Previous distal aortic repairz .7 .2
Operative
Urgent repair .1 .8
Emergency repair 1.0 .4
Extraction of endovascular graft 1.0 .4
Redo thoracotomy 1.0 1.0
Extent II TAAA repair .3 .5
Clamping proximal to LSCA .004 .005
Reverse elephant trunk .2 .1
Use of cerebrospinal fluid drain .3 .4
Use of LHB .1 .058
Increasing LHB durationx .6 .6
Use of HCA .002 .006
Use of cold renal perfusionk <.001 .03
Postoperative
Pulmonary complications <.001 <.001
Need for tracheostomy .054 .2
Permanent stroke .003 —
Permanent renal failure .001 —
Permanent paraplegia 1.0 —
HCA, Hypothermic circulatory arrest; LHB, left heart bypass; LSCA, left subclavian
artery; TAAA, thoracoabdominal aortic aneurysm. *Adverse event is a composite
endpoint that includes operative death (in-hospital or 30-day death) and permanent
(ie, present at hospital discharge) stroke, renal failure, paraplegia, or paraparesis.
yNonrupture-complicating factor at the time of distal aortic repair includes infected
graft or endograft, fistula, pseudoaneurysm, and intercostal or visceral patch aneu-
rysm. zIncludes both open and endovascular aortic repairs. xAvailable for 139 of
140 repairs involving LHB. kA protective effect was identified (Pearson test
statistic ¼ 14.2697).
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distal aortic repairs.12 This difference is probably related
to the more frequent use of HCA in the current series
(8%, rather than our prior 2%), which was due to the
increased complexity of these cases; we generally reserve
HCA for repairs in which a clamp cannot be placed on the2990 The Journal of Thoracic and Cardiovascular Suraorta proximal to the portion necessitating repair, for
example, in cases of enormous aneurysm size, acute
rupture, or impingement of an existing stent-graft across
the arch, and in repairs extending into the arch (n ¼ 5).
The use of HCA was strongly associated with early death
(P ¼ .002) and adverse event (P ¼ .006). In addition,
74% of repairs in this series were extensive (extent I or
II TAAA repairs), and aortic pathology necessitated initial
aortic clamping proximal to the left subclavian artery in
many repairs (n¼ 78; 39%). We found that such clamping
was significantly associated with both early death and
adverse event; this has been substantiated by others in
open repair of chronic distal aortic dissection.14 Of note,
we found no association between preoperative cerebrovas-
cular disease and early death (P ¼ 1.0) or adverse event
(P ¼ .8).
Likewise, the rates of postoperative renal dysfunction
and permanent renal failure were similar to those in our pre-
viously published contemporary TAAA experience12 even
though cold renal perfusion was used in substantially fewer
repairs in the current series (62% vs 82%). Although it is
possible that the younger age of our cohort may have
been of benefit, univariate analysis associated cold renal
perfusion with protection against early death (P< .001)
and adverse event (P ¼ .03). Our 2 previous randomized
clinical trials also showed the benefits of cold renal perfu-
sion.7,8 In the current study, permanent renal failure was
associated with early death (P<.001). Of the 9 repairs in
patients who developed permanent renal failure, none had
preoperative creatinine levels greater than 3.0 mg/dL, and
7 had levels less than 1.5 mg/dL. Thus, it remains difficult
to predict renal failure preoperatively.
Although the atherosclerotic process is thought to be an
important mechanism in the development of distal
aortic aneurysm in patients without aortic dissection,
the process behind aneurysmal development in patients
with chronic DeBakey I dissection is not yet clear.15,16
For incompletely understood reasons, the residual
dissected aorta tends to dilate faster than the
nondissected aorta,17 aortic expansion appears greatest
when the false lumen is partly thrombosed compared
with fully thrombosed or fully patent false lumens,18 and
the onset of distal aortic enlargement is highly unpredict-
able.19 Of note, patients undergoing distal aortic repair
related to chronic dissection tend to be younger14,20 and
may have a lesser atherosclerotic burden than patients
without dissection. Endarterectomy of branching vessels
is commonly needed in patients with atherosclerosis;
however, only 3 of our 171 repairs (2%) of chronic-
dissection–related TAAA involved concomitant
endarterectomy, compared with 33% of 823 TAAA
repairs that we recently reported,12 and up to 51% of oc-
togenarians with TAAA repair (unpublished data). Thus,
we speculate that most aneurysms in the current seriesgery c December 2014
FIGURE 1. Kaplan–Meier curves regarding 198 distal aortic repairs in patients with chronic DeBakey type I aortic dissection showing (A) survival esti-
mate, (B) freedom from repair failure, (C) freedom from reintervention for disease progression, and (D) freedom from repair failure or reintervention for
disease progression.
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rotic process.
Site-specific repair failure (Table E2) was rare but often
deadly (5/7; 71%). Although the presence of pseudoaneur-
ysm was uncommon both preoperatively (n ¼ 1) and
postoperatively (n ¼ 3), it appears to be the most easily
treated failure; 2 of 3 patients survived this complication
after rescue with an endovascular graft-within-a-graft
approach.21 Three of 7 failures occurred in cases involving
the extraction of previously placed stent-grafts; as detailed
in a previous publication,22 repair in such cases is often
complicated by preoperative infection or fistula. Likewise,
the development of postoperative fistula was difficult to
treat—both of the affected patients died.
Survivors of DeBakey type I aortic dissection clearly face
an uncertain future regarding the progression of aortic dis-
ease; aortic events commonly take place over 2 or 3 decades
and often necessitate multiple aortic interventions. Most pa-
tients had a complex history of both preoperative and post-
operative aortic repair. In approximately one third of
patients (n ¼ 61), the full aortic arch was replaced preoper-
atively. Seven patients had subsequent repair of the aortic
arch (including 3 reversed elephant trunk completions); 6
patients survived repair, and the only death was related to
concomitant aortic root replacement due to graft infection.
Thus, in approximately two thirds of patients, the aortic
arch did not dilate sufficiently to warrant operativeThe Journal of Thoracic and Carreintervention. Although antegrade TEVAR and FET ap-
proaches in acute DeBakey type I aortic dissection are
thought to be more useful in preventing late distal aortic
events than in treating the aortic arch per se, early experi-
ence with modified FET approaches show that late reinter-
vention rates are highest in FET approaches (25%)
compared with endovascular repair for other aortic pathol-
ogies, such as for chronic type B dissection (12%) or infec-
tion (20%); these FET reinterventions were performed
because of poor remodeling of the distal aorta and persistent
patency of the false lumen.23 In addition, the enhanced risk
of spinal cord ischemia during antegrade TEVAR and FET
procedures remains a concern.3,24
Thoracic endovascular repair is now approved for use in
aortic dissection and is a tempting strategy for patients and
clinicians alike, largely because of the purported reduction
in operative death. However, it is not yet clear that such
repair slows aortic expansion in cases of chronic dissection,
especially the extensive dissection that is present in DeBa-
key type I pathology. Emerging data suggest that the need
for reintervention is greater after TEVAR for chronic distal
aortic dissection than after TEVAR for aneurysm.25 More-
over, endograft extraction after TEVAR for such dissection
in not uncommon; this seems to be related to the persistent
growth of the false lumen,26,27 and extremely rapid aortic
dilatation has been documented after endovascular repair
in the chronically dissected aorta.22diovascular Surgery c Volume 148, Number 6 2991
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Limitations of this report include that it is a single surgi-
cal practice experience, with a potential for referral bias and
includes in part retrospective data. In addition, we were un-
able to determine the cause of late death in 9 patients. It is
possible that some or all of these deaths were aortic related
and involved rupture of previously unreplaced aortic seg-
ments; significant portions of the aortic arch remained in
approximately half of the cases (full arch replaced in 4 pa-
tients), and most had a significant portion of the distal aorta
replaced (extent II TAAA repair in 7 patients). These deaths
could represent an undetermined repair failure, such as the
rupture of a pseudoaneurysm or patch aneurysm. Further-
more, the 6 patients without current follow-up and whom
the SSDI shows to be alive could have had a nonlethal repair
failure. In many repairs, it was not possible to elucidate fac-
tors related to the onset and progression of DeBakey type I
aortic dissection; this is mainly because acute proximal
aortic dissection necessitates immediate repair, whereas
most repairs for chronic distal aortic dissection are elective,
and tertiary centers of expertise are commonly sought out.
This referral pattern of patients who were initially treated
outside our geographic location (n ¼ 165) may have
contributed to the difficulty in obtaining late clinical
follow-up.CONCLUSIONS
In survivors of DeBakey type I aortic dissection, it is
difficult to predict whether and when late distal aortic repair
will be necessary, so adherence to a lifelong imaging
surveillance protocol is crucial. Patients should be
counseled regarding the progressive nature of extensive
aortic dissection and made aware that multiple interven-
tions may be needed. If and when open distal aortic repair
is needed, patients should be assured that open repair of
the descending thoracic or thoracoabdominal aorta poses
a low risk of early mortality or serious morbidity and that
late aortic events are unlikely.
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DDiscussion
Dr D. Craig Miller (Stanford, Calif). Joe, that was perfect.
Crisp and quick. I want to thank you because I believe I heard
the term ‘‘Stanford type A’’ once. Appreciate that.
Dr Coselli. You’re welcome.
Dr Miller. We have several balls, or unanswered questions, in
the air here. The simplest question actually is probably the one
you answered today. We know the numerator consisting of the
number of people who required another downstream operation,
and you have shown clearly using modern open surgical tech-
niques that the risk of these reoperations is low and the 5-year
durability is reasonable. Eric Roselli, the late Roy Greenberg,
Lars Svensson, and the Cleveland Clinic group have shown that
endovascular TEVAR or open surgical repair of descending aortic
chronic dissections is associated with a similarly low operative risk
and similar short-term outcomes. Not to get sidetracked, whether
TEVAR is effective treatment for chronic dissections of the DTA
is a separate, controversial topic begging for the proper random-
ized prospective clinical trial. Nonetheless, we all can agree on
the answer to the first question: When necessary, surgical repair
of the downstream descending or thoracoabdominal chronic aortic
dissection in experienced, high-volume centers is relatively safe
and efficacious.
The bigger unanswered question is what is the denominator?
We need this number to estimate how many patients surviving
an acute type A dissection eventually need something done down-
stream and characterize which patients are at higher risk of reop-
eration, for example, possibly those with a connective tissue
disorder, to learn what can we do at the first operation to reduce
the incidence of late reoperation and sudden, unexplained late
deaths. You mentioned that some of these patients die later on
and some may die of downstream aortic complications because
they did not undergo reoperation, an area ripe for potential
improvement.
So what we can do better during the initial acute dissection
operation in patients who are at higher risk for subsequent down-
stream aortic false lumen enlargement of the thoracoabdominal
chronic dissection? Dr Kazui in Japan (eg, total arch replacement
in selected patients with theMarfan syndrome), Daniel Loisance at
the Hospital Mo^ndor in Paris, and Marc Moon at Washington
University have analyzed if performing a more radical operation
the first time reduces the need for subsequent downstream
reoperation, but none have shown success. As exemplified by the
report from Paris by Loisance and colleagues, the incidence of
reoperation paradoxically increases over time because ourThe Journal of Thoracic and Carthreshold to do something downstream declines over the years,
that is, our indications for reintervention become more aggressive.
So, we have a ‘‘moving goal posts’’ problem, which makes it tough
to answer this question short of a randomized prospective clinical
trial.
Nonetheless, you mentioned adding a stent-graft or FET in the
DTA at the time of the initial acute dissection operation. This
seems to be the most popular technique being tried now, as your
Baylor team, Eric Roselli at the Cleveland Clinic, Alberto Pochet-
tino and others in the United States, several European groups, and
Dr Sun in Beijing often place a standard stent-graft into the distal
end of the replacement graft, but in Europe a specialty hybrid de-
vice (an open replacement graft combined with a stent-graft) is
placed in the true lumen of the proximal DTA during the initial
emergency arch/ascending aortic replacement hoping to reduce
the incidence of late downstream false aneurysmal degeneration
and need for reoperation.
How are we going to sort out whether a more radical approach
like this at the time of the initial operation—and in which patients
it is needed—is justified without knowing the denominator and
given the fact that our reintervention endpoints are changing
over time? As you yourself have stated, any time you do something
beyond the left subclavian at the time of the first operation for
acute type A dissection you add incremental risk, namely, the
risk of paraplegia. Further, the new German GERAADA registry
data demonstrate that if one replaces the arch when you otherwise
would not have to, you increase the early acute type A dissection
operative mortality rate by 10% in Germany. How do we sort out
this conundrum? Who is going to pay for the randomized clinical
trial that is obviously required?
Dr Coselli. Well, thank you, Dr Miller. I don’t have an answer
for this conundrum, and the fact that you don’t either is probably
why it remains a conundrum. Clearly in this work, we are dealing
with the numerator and not the denominator, and, as at most of our
institutions, many of these patients come from far and wide and are
extremely difficult to follow up. So, determining the denominator
is challenging.
You are absolutely right. When we have tried an expanded
approach to repair at the initial operation, with an aim to reduce
the likelihood of a second operation, we do that at a price.
Expanded approaches have included total arch replacement, and,
as you mentioned, the operation de jour, which is to place a stent
graft in the true lumen at the initial procedure. These approaches
increase early risk; as you mentioned from the German Registry
for Acute Aortic Dissection Type A (GERAADA) study, the total
arch approach carries a 10% risk in mortality, and in the latter there
is a risk of paraplegia. But trying to balance out these initial mor-
bidities and mortalities with what is best in the long term is what
we are trying to establish. Such work would give us a benchmark
by which to compare these other techniques, both in the short term
and the long term, but a great deal morework is going to have to be
done to sort this out.
Dr E. Roselli (Cleveland, Ohio). My question is about the fate
of the aortic arch. I noted that you reoperated on 7 of those. Were
those patients who had the reverse elephant trunk technique,
numbers 1 and 2, the ones in whom the native arch was left behind,
was that chronically dissected, and how do you make the decision
about how to operate on that intervening segment?diovascular Surgery c Volume 148, Number 6 2993
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DDr Coselli. For the last part, the decision to operate on the arch
is primarily determined by the rate of increase in size, the develop-
ment of symptoms, and the absolute size, using approximately 6 to
6-1/2 cm diameter in that particular location. All of the patients in
this group had chronic dissection of the transverse aortic arch. As2994 The Journal of Thoracic and Cardiovascular Surwe all well know, the arch is usually the last thing to dilate.
This adds to the discussion about how aggressive to be at the
initial operation, and only a couple of patients in this series have
returned for arch repair after undergoing a reverse elephant trunk
procedure.gery c December 2014
FIGURE E1. Actuarial survival stratified by extent II TAAA repair versus all other repairs (A) and by genetic disorder versus no genetic disorder (B).
Patients in both of these selected subgroups were substantially younger when they underwent distal aortic repair—median ages were 51.8 versus 58.7 years
and 47.1 versus 62.0 years, respectively. The comparisons were computed using the log rank (Mantel–Cox), Breslow (generalized Wilcoxon), and Tarone–
Ware tests; the P value reported is derived from the log-rank test.
TABLE E1. Early outcomes by extent II thoracoabdominal aortic aneurysm repair and genetic disorder
Complication
All repairs (n ¼ 198)
No. (%)
Extent II TAAA repair
(n ¼ 80) No. (%) P value
Genetic disorder
(n ¼ 110) No. (%) P value
Adverse outcome (composite endpoint) 24 (12.1) 8 (10.0) .5 12 (10.9) .6
Operative (early) death 14 (7.1) 4 (5.0) .3 6 (5.5) .3
Permanent stroke 5 (2.5) 2 (2.5) 1.0 1 (0.9) .2
Permanent paraplegia 2 (1.0) 0 .5 0 .2
Permanent paraparesis 3 (1.5) 1 (1.3) .6 2 (1.8) 1.0
Permanent renal failure (need for dialysis) 9 (4.6) 4 (5.0) 1.0 6 (5.5) .7
Cardiac complication 56 (28.3) 24 (30.0) .7 26 (23.6) .1
Pulmonary complication 78 (39.4) 31 (38.8) .9 37 (33.6) .064
The P value is as compared with the non-extent II repair group (DTA, extent I, extent III, extent IV) and the nongenetic disorder group, respectively. Adverse event is a composite
endpoint that includes operative death (in-hospital or 30-day death) and permanent (present at hospital discharge) stroke, renal failure, paraplegia, or paraparesis. TAAA, Thor-
acoabdominal aortic aneurysm.
TABLE E2. Site-specific late failures and related reinterventions
Age (y) POD Description of event
53 50 Development of pseudoaneurysm (at mid-descending thoracic level) and intercostal patch aneurysm necessitated
endovascular reintervention by an endograft-within-graft approach; alive at POD 1868
50 61 Hemoptysis after development of aortobronchial fistula and complicated by sepsis after endograft extraction; death
at POD 62
63 7 Exsanguination due to aortoesophageal fistula at graft-to-graft anastomosis; death at POD 8
62 1224 Rupture of pseudoaneurysm of DTA; death at POD 1228
61 78 Graft infection without open reintervention; death at POD 276
56 38 Development of pseudoaneurysm (at suture line of prior elephant trunk and extent II graft) necessitated endovascular
reintervention by an endograft-within-graft approach; additional open repair 2 d later to reattach the visceral patch,
which had dehisced at the proximal anastomosis; alive at POD 1981
61 52 Recurrent infection and recurrent aortobronchial fistula in patient with prior endograft extraction; death at POD 204
DTA, Descending thoracic aorta; POD, postoperative day.
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TABLE E3. Description of 17 repairs for disease progression
Age (y) GD POD Description of event
22 Y 490 TAAA extent IV repair after DTA repair; alive POD 2436
53 N 1443 TAAA extent III repair after DTA repair; alive POD 1730
59 Y 346 TAAA extent III repair after TAAA extent I repair; alive POD 1263
62 Y 277 TAAA extent III repair after DTA repair; related death at POD 285
32 Y 527 TEVAR of distal aortic arch and proximal edge of replacement graft to treat new symptoms; alive POD 1128
50 Y 385 EVAR after TAAA extent II repair; alive POD 1519
35 Y 70 EVAR after TAAA extent II repair; alive POD 2816
48 Y 1483 EVAR after TAAA extent II repair; alive POD 3024
62 N 1725 EVAR after TAAA extent IV repair; alive POD 3138
66 N 854 Open abdominal aortic repair after TAAA extent IV repair; alive POD 3081
31 Y 2430 Open aortic arch repair (with redo root) after TAAA extent II; alive POD 2662
57 N 262 Open aortic arch repair (with redo root for graft infection) after TAAA extent I; death at POD 284
45 Y 2858 Open aortic arch after TAAA extent II repair with RET; alive POD 2886
59 N 1240 Open aortic arch repair TAAA extent I repair; alive POD 2547
56 Y 503 Open aortic arch repair (with redo aortic root) after TAAA extent II repair; alive POD 1700
35 Y 705 Open aortic arch (with redo ascending repair) after TAAA extent II repair with RET; alive POD 1968
35 Y 805 Open aortic arch repair after TAAA extent II repair with RET; alive POD 1153
DTA, Descending thoracic aorta; EVAR, endovascular aortic repair; GD, genetic disorder; POD, postoperative day; RET, reverse elephant trunk; TAAA, thoracoabdominal aortic
aneurysm; TEVAR, thoracic endovascular aortic repair.
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